financetom
Business
financetom
/
Business
/
Zentalis Pharmaceuticals 2025 Loss Narrows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zentalis Pharmaceuticals 2025 Loss Narrows
Mar 26, 2026 2:11 PM

04:45 PM EDT, 03/26/2026 (MT Newswires) -- Zentalis Pharmaceuticals ( ZNTL ) late Thursday reported a 2025 loss of $1.91 per diluted share, narrowing from a loss of $2.33 a year earlier.

Analysts surveyed by FactSet expected loss of $1.82.

As of Dec. 31, the company said it had $245.9 million in cash, cash equivalents and marketable securities, with projected cash runway into late 2027.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Parsons Increases Share Buyback Authorization to $250 Million
Parsons Increases Share Buyback Authorization to $250 Million
Mar 24, 2025
04:29 PM EDT, 03/24/2025 (MT Newswires) -- Parsons (PSN) said late Monday its board has increased the company's stock buyback authorization to $250 million. The shares were up about 1.7% in extended trading. ...
What's Going On With Ford Stock Today?
What's Going On With Ford Stock Today?
Mar 24, 2025
Ford Motor Co ( F ) stock traded higher Monday amid reports that upcoming U.S. tariffs could be more targeted than initially expected. What To Know: The market has been wary of sweeping tariffs that could raise costs and disrupt supply chains, but a more targeted approach could lessen the impact on companies like Ford. The broader market, especially tech...
Skyx Platforms Narrows 2024 Net Loss, Revenue Increases
Skyx Platforms Narrows 2024 Net Loss, Revenue Increases
Mar 24, 2025
04:29 PM EDT, 03/24/2025 (MT Newswires) -- Skyx Platforms ( SKYX ) late Monday reported a 2024 net loss of $0.36 per diluted share compared with a $0.45 loss a year earlier. Three analysts polled by FactSet, on average, expected a $0.34 loss. Revenue for the 12 months ended Dec. 31 was $86.3 million, compared with $58.8 million a year...
OpenAI COO to lead global growth push in expanded role, Altman says
OpenAI COO to lead global growth push in expanded role, Altman says
Mar 24, 2025
March 24 (Reuters) - OpenAI's Chief Operating Officer Brad Lightcap will spearhead global expansion and corporate partnerships, CEO Sam Altman said on Monday, as the Microsoft ( MSFT )-backed startup seeks to cement its dominance in the rapidly growing AI industry. Altman will increasingly focus on the technical side to boost the ChatGPT-maker's research and product initiatives, while remaining in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved